Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Details

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Halis Akturk and Kagan Karakus.

 
Connection Strength
  
 
 
10.660
  
  1. Karakus KE, Mason E, Akturk HK. Flying With Type 1 Diabetes as Commercial Airline Pilots in the U.S.: The Sky Is the Limit for People With Type 1 Diabetes. Diabetes Care. 2025 Apr 01; 48(4):e54-e55.
    View in: PubMed
    Score: 0.959
  2. Karakus KE, Shah VN, Akturk HK. Antihypertensive Medications in Patients With Weight Loss-Reply. JAMA Intern Med. 2025 Apr 01; 185(4):475-476.
    View in: PubMed
    Score: 0.959
  3. Akturk HK, Mason E, Snell-Bergeon J, Shah VN, Karakus KE. Differentiating Diabetic Gastroparesis and Cannabis Hyperemesis Syndrome in People With Type 1 Diabetes. Clin Diabetes. 2025; 43(3):416-419.
    View in: PubMed
    Score: 0.955
  4. Karakus KE, Akturk HK. Cannabis Hyperemesis Syndrome Can Mimic Diabetic Gastroparesis in Cannabis Users With Type 1 Diabetes. Can J Diabetes. 2025 Apr; 49(3):218-219.
    View in: PubMed
    Score: 0.952
  5. Karakus KE, Snell-Bergeon J, Mason E, Akturk HK. Improvement in Newly Defined Continuous Glucose Monitor Metrics, Extended Hypoglycemia, and Extended Hyperglycemia With Automated Insulin Delivery Initiation in Adults With Type 1 Diabetes. J Diabetes Sci Technol. 2024 Dec 05; 19322968241301429.
    View in: PubMed
    Score: 0.938
  6. Karakus KE, Snell-Bergeon JK, Akturk HK. Comparison of Computational Statistical Packages for the Analysis of Continuous Glucose Monitoring Data with a Reference Software, "Ambulatory Glucose Profile," in Type 1 Diabetes. Diabetes Technol Ther. 2025 Mar; 27(3):202-208.
    View in: PubMed
    Score: 0.933
  7. Karakus KE, Mason E, Akturk HK. Long-term glycaemic improvement with the initiation of an automated insulin delivery system in insulin pump-naïve older adults with type 1 diabetes. Diabetes Obes Metab. 2025 Jan; 27(1):410-413.
    View in: PubMed
    Score: 0.928
  8. Karakus KE, Shah VN, Akturk HK. Tirzepatide-Induced Rapid Weight Loss-Related Thyrotoxicosis. JAMA Intern Med. 2024 Oct 01; 184(10):1246-1247.
    View in: PubMed
    Score: 0.927
  9. Karakus KE, Shah VN, Klonoff D, Akturk HK. Changes in the glycaemia risk index and its association with other continuous glucose monitoring metrics after initiation of an automated insulin delivery system in adults with type 1 diabetes. Diabetes Obes Metab. 2023 11; 25(11):3144-3151.
    View in: PubMed
    Score: 0.851
  10. Akturk HK, Karakus KE, Chen B, Walker TC. Exploring the Relationship Between Newly Defined Continuous Glucose Monitoring (CGM) Metrics and the Standard CGM Metrics in 30,000 People with Type 1 Diabetes. Diabetes Technol Ther. 2025 Sep 11.
    View in: PubMed
    Score: 0.247
  11. Mason E, Karakus KE, Akturk HK. Barriers to glucagon use in patients with type 1 diabetes. Prim Care Diabetes. 2025 Jun; 19(3):341-343.
    View in: PubMed
    Score: 0.239
  12. Karakus KE, Akturk HK, Snell-Bergeon JK, Shah VN. Progression of Diabetic Retinopathy After Initiation of Automated Insulin Delivery System in Adults With Type 1 Diabetes. J Diabetes Sci Technol. 2025 Feb 14; 19322968251318740.
    View in: PubMed
    Score: 0.238
  13. Akturk HK, Karakus KE, D'Souza E, Assadi KZ, Pinsker JE, Messer LH. Glycemic and Patient-Reported Outcomes for Users of a New, Compact Automated Insulin Delivery System: A First Report. J Diabetes Sci Technol. 2025 Mar; 19(2):582-583.
    View in: PubMed
    Score: 0.234
  14. Karakus KE, Klein MP, Akturk HK, Shah VN. Changes in Basal and Bolus Insulin Requirements with Tirzepatide as an Adjunctive Therapy in Adults with Type 1 Diabetes Using Tandem Control-IQ. Diabetes Ther. 2024 Jul; 15(7):1647-1655.
    View in: PubMed
    Score: 0.226
  15. Akturk HK, Michel K, Couts K, Karakus KE, Robinson W, Michels A. Routine Blood Glucose Monitoring Does Not Predict Onset of Immune Checkpoint Inhibitor-Induced Type 1 Diabetes. Diabetes Care. 2024 Mar 01; 47(3):e29-e30.
    View in: PubMed
    Score: 0.222
  16. Akturk HK, Dong F, Snell-Bergeon JK, Karakus KE, Shah VN. Efficacy and Safety of Tirzepatide in Adults With Type 1 Diabetes: A Proof of Concept Observational Study. J Diabetes Sci Technol. 2025 Mar; 19(2):292-296.
    View in: PubMed
    Score: 0.221
  17. Karakus KE, Akturk HK, Alonso GT, Snell-Bergeon JK, Shah VN. Association Between Diabetes Technology Use and Glycemic Outcomes in Adults With Type 1 Diabetes Over a Decade. Diabetes Care. 2023 09 01; 46(9):1646-1651.
    View in: PubMed
    Score: 0.215
  18. Akturk HK, Snell-Bergeon J, Karakus KE, Shah VN. Assessing the relationship between low-calorie sweetener use and quality of life measures in adults with type 1 diabetes. BMC Endocr Disord. 2023 Jul 11; 23(1):147.
    View in: PubMed
    Score: 0.213
  19. Akturk HK, Couts KL, Baschal EE, Karakus KE, Van Gulick RJ, Turner JA, Pyle L, Robinson WA, Michels AW. Analysis of Human Leukocyte Antigen DR Alleles, Immune-Related Adverse Events, and Survival Associated With Immune Checkpoint Inhibitor Use Among Patients With Advanced Malignant Melanoma. JAMA Netw Open. 2022 12 01; 5(12):e2246400.
    View in: PubMed
    Score: 0.204
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)